These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34114043)

  • 21. CD99 immunoreactivity in ependymoma.
    Choi YL; Chi JG; Suh YL
    Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pay attention to molecular pathological diagnosis of pediatric glioma].
    Teng LH; Lu DH
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(19):1411-1416. PubMed ID: 35599404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnostics in central nervous system tumors.
    Fuller CE; Perry A
    Adv Anat Pathol; 2005 Jul; 12(4):180-94. PubMed ID: 16096380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in subtyping tumors of the central nervous system using molecular data.
    Schittenhelm J
    Expert Rev Mol Diagn; 2017 Jan; 17(1):83-94. PubMed ID: 27893285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Glial Tumors.
    Viaene AN; Santi M; Hawkins C
    Pediatr Dev Pathol; 2022; 25(1):46-58. PubMed ID: 33872106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System.
    Meredith DM
    Adv Anat Pathol; 2020 May; 27(3):206-219. PubMed ID: 30720470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
    Berger TR; Wen PY; Lang-Orsini M; Chukwueke UN
    JAMA Oncol; 2022 Oct; 8(10):1493-1501. PubMed ID: 36006639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
    Fuller CE; Jones DTW; Kieran MW
    Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic analysis of 109 pediatric central nervous system tumors.
    Neumann E; Kalousek DK; Norman MG; Steinbok P; Cochrane DD; Goddard K
    Cancer Genet Cytogenet; 1993 Nov; 71(1):40-9. PubMed ID: 8275451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shared molecular targets in pediatric gliomas and ependymomas.
    Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
    Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of gliomas: from morphology to molecules.
    Ferris SP; Hofmann JW; Solomon DA; Perry A
    Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Emerging Molecular Foundations of Pediatric Brain Tumors.
    Huse JT; Rosenblum MK
    J Child Neurol; 2015 Nov; 30(13):1838-50. PubMed ID: 25873586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gray zones in brain tumor classification: evolving concepts.
    Trembath D; Miller CR; Perry A
    Adv Anat Pathol; 2008 Sep; 15(5):287-97. PubMed ID: 18724102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.
    Sturm D; Capper D; Andreiuolo F; Gessi M; Kölsche C; Reinhardt A; Sievers P; Wefers AK; Ebrahimi A; Suwala AK; Gielen GH; Sill M; Schrimpf D; Stichel D; Hovestadt V; Daenekas B; Rode A; Hamelmann S; Previti C; Jäger N; Buchhalter I; Blattner-Johnson M; Jones BC; Warmuth-Metz M; Bison B; Grund K; Sutter C; Hirsch S; Dikow N; Hasselblatt M; Schüller U; Koch A; Gerber NU; White CL; Buntine MK; Kinross K; Algar EM; Hansford JR; Gottardo NG; Schuhmann MU; Thomale UW; Hernáiz Driever P; Gnekow A; Witt O; Müller HL; Calaminus G; Fleischhack G; Kordes U; Mynarek M; Rutkowski S; Frühwald MC; Kramm CM; von Deimling A; Pietsch T; Sahm F; Pfister SM; Jones DTW
    Nat Med; 2023 Apr; 29(4):917-926. PubMed ID: 36928815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric central nervous system tumors.
    Reddy AT; Packer RJ
    Curr Opin Oncol; 1998 May; 10(3):186-93. PubMed ID: 9619353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.
    Grill J; Avet-Loiseau H; Lellouch-Tubiana A; Sévenet N; Terrier-Lacombe MJ; Vénuat AM; Doz F; Sainte-Rose C; Kalifa C; Vassal G
    Cancer Genet Cytogenet; 2002 Jul; 136(2):121-5. PubMed ID: 12237235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part I-Key Concepts and the Spectrum of Diffuse Gliomas.
    Johnson DR; Giannini C; Vaubel RA; Morris JM; Eckel LJ; Kaufmann TJ; Guerin JB
    Radiology; 2022 Sep; 304(3):494-508. PubMed ID: 35880978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.